Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-149-4 | CAS number: 7789-21-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1987
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- : only 4 strains, no strains with AT base pair at the primary reversion site, culture media used not reported
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Sodium fluoride
- EC Number:
- 231-667-8
- EC Name:
- Sodium fluoride
- Cas Number:
- 7681-49-4
- Molecular formula:
- NaF
- IUPAC Name:
- sodium fluoride
- Details on test material:
- - Name of test material (as cited in study report): NaF
- Molecular formula (if other than submission substance): NaF
- Molecular weight (if other than submission substance): 42 g/mol
- Physical state: solid (white powder)
- Analytical purity: 99.4%
- Purity test date: May 5, 1987
- Lot/batch No.: 26061987 (internal)
- Stability under test conditions: aqueous suspensions of NaF are stable under the experimental conditions. According to the sponsor, the compound is stable for storage for at least the test period.
- Storage condition of test material: refrigerator
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- other: partly deficient in lipopolysaccharide side chains of their cell walls, UV repair ability malfunctions
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- first test: 0, 20, 100, 500, 2500, 12500 µg per plate
repeat test: 0, 375, 750, 1500, 3000, 6000, 12000 µg per plate - Vehicle / solvent:
- the solvent used for NaF was demineralized water, and for the positive controls DMSO
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: -S9: sodium azide (only TA 1535), nitrofurantoin (only TA 100), 4-nitro-1,2-phenylenediamine (TA 1537 + TA 98), +S9: 2-aminoanthracene
- Remarks:
- no
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 h
NUMBER OF REPLICATIONS:
four plates per strain and dose, both with and without S-9 mix, were used for mutant count. Four plates per strain were also used for each positive control.
DETERMINATION OF CYTOTOXICITY
- other: background growth on the plates for the mutant determination; toxic effect assumed when mutant count per plate was clearly lower than the negative control count in dose correlation; determination of titer
- Evaluation criteria:
- A reproducible and dose-related increase (ie. at least twice the negative control count) in mutant counts for at least one strain was considered positive.
In the case of no reproducible and dose-related increase in mutant counts in at least one strain, the result was evaluated as negative.
In the case of questionable results, the investigations continued, probably by the use of modifications, until a final evaluation was possible.
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- : Doses up to and including 6000 µg per plate did not cause any bacteriotoxic effects. At higher doses, the substance had only a weak bacteriotoxic effect in TA 1535 and TA 100, so that this range could nevertheless be used for evaluation purposes.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- other: strain/cell type: S. typhimurium TA1535, TA100, TA1537, TA98
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
None of the four strains used showed a dose-related and biologically relevant increase in mutant counts over those of the negative controls. This applied both to the tests with and without S-9 mix and was confirmed by the results of the repeat tests.
Table 1. Summary of the results of the Ames test on NaF without S-9 mix
|
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
||||||||
Test/doses |
Means |
Titer per ml 108 |
Quotient |
Means |
Titer per ml 108 |
Quotient |
Means |
Titer per ml 108 |
Quotient |
Means |
Titer per ml 108 |
Quotient |
1sttest |
||||||||||||
0 |
11 |
30.8 |
1.0 |
61 |
6.4 |
1.0 |
7 |
37.6 |
1.0 |
16 |
56.0 |
1.0 |
20 |
11 |
24.4 |
1.0 |
72 |
7.7 |
1.2 |
7 |
33.7 |
1.0 |
16 |
58.0 |
1.0 |
100 |
9 |
27.7 |
0.8 |
74 |
7.9 |
1.2 |
6 |
35.1 |
0.9 |
23 |
64.6 |
1.4 |
500 |
10 |
35.3 |
0.9 |
71 |
12.9 |
1.2 |
5 |
34.1 |
0.6 |
16 |
53.0 |
1.0 |
2500 |
9 |
35.1 |
0.8 |
67 |
12.6 |
1.1 |
6 |
35.3 |
0.8 |
19 |
54.3 |
1.2 |
12500 |
9 |
17.9** |
0.8 |
69 |
7.2 |
1.1 |
5 |
32.9 |
0.7 |
17 |
66.8 |
1.0 |
Na-Azide |
601 |
36.4 |
55.9* |
|
|
|
|
|
|
|
|
|
NF |
|
|
|
217 |
9.1 |
3.6* |
|
|
|
|
|
|
4-NPDA |
|
|
|
|
|
|
48 |
34.8 |
6.6* |
93 |
59.6 |
5.7* |
2-AA (+S9) |
|
38.7 |
|
|
11.9 |
|
|
34.6 |
|
|
49.4 |
|
2ndtest |
||||||||||||
0 |
14 |
48.6 |
1.0 |
64 |
20.9 |
1.0 |
7 |
50.8 |
1.0 |
17 |
62.0 |
1.0 |
375 |
15 |
45.7 |
1.1 |
57 |
11.3 |
0.9 |
6 |
47.8 |
0.9 |
14 |
65.2 |
0.9 |
750 |
13 |
49.2 |
0.9 |
62 |
9.9 |
1.0 |
5 |
39.2 |
0.7 |
19 |
63.9 |
1.1 |
1500 |
12 |
48.2 |
0.9 |
56 |
10.4 |
0.9 |
8 |
48.5 |
1.3 |
18 |
67.6 |
1.1 |
3000 |
16 |
46.1 |
1.1 |
66 |
10.0 |
1.0 |
8 |
47.6 |
1.2 |
20 |
69.2 |
1.2 |
6000 |
14 |
51.3 |
1.0 |
67 |
10.1 |
1.0 |
5 |
49.4 |
0.8 |
15 |
73.8 |
0.9 |
12000 |
15 |
26.1** |
1.1 |
77 |
7.4 |
1.2 |
5 |
45.7 |
0.8 |
15 |
80.0 |
0.9 |
Na-Azide |
922 |
49.9 |
67.0* |
|
|
|
|
|
|
|
|
|
NF |
|
|
|
257 |
13.2 |
4.0* |
|
|
|
|
|
|
4-NPDA |
|
|
|
|
|
|
68 |
57.8 |
10.4* |
130 |
53.5 |
7.7* |
2-AA (+S9) |
|
54.8 |
|
|
13.3 |
|
|
58.1 |
|
|
58.3 |
|
Na-Azide: Sodium azide, 10 µg/plate
NF: Nitrofurantoin, 0.2 µg/plate
4-NPDA: 4-nitro-1,2-phenylenediamine, 0.5 µg/plate
2-AA: 2-aminoanthracene, 3 µg/plate
* = mutagenic effect
** =bacteriotoxic effect
Table 2. Summary of the results of the Ames test on NaF with S-9 mix
|
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
||||
Test/doses |
Means |
Quotient |
Means |
Quotient |
Means |
Quotient |
Means |
Quotient |
1sttest |
|
|
|
|
|
|
|
|
0 |
15 |
1.0 |
132 |
1.0 |
8 |
1.0 |
44 |
1.0 |
20 |
17 |
1.1 |
122 |
0.9 |
8 |
1.0 |
35 |
0.8 |
100 |
16 |
1.1 |
107 |
0.8 |
8 |
1.0 |
33 |
0.7 |
500 |
19 |
1.3 |
128 |
1.0 |
9 |
1.1 |
29 |
0.7 |
2500 |
19 |
1.3 |
85 |
0.6 |
6 |
0.8 |
45 |
1.0 |
12500 |
18 |
1.2 |
48** |
0.4 |
4 |
0.5 |
35 |
0.8 |
2-AA |
143 |
9.7* |
395 |
3.0* |
27 |
3.5* |
373 |
8.6* |
2ndtest |
|
|
|
|
|
|
|
|
0 |
23 |
1.0 |
104 |
1.0 |
9 |
1.0 |
49 |
1.0 |
375 |
28 |
1.2 |
105 |
1.0 |
10 |
1.1 |
43 |
0.9 |
750 |
25 |
1.1 |
128 |
1.2 |
11 |
1.3 |
36 |
0.7 |
1500 |
19 |
0.8 |
108 |
1.0 |
7 |
0.8 |
42 |
0.9 |
3000 |
24 |
1.0 |
133 |
1.3 |
7 |
0.8 |
53 |
1.1 |
6000 |
20 |
0.9 |
132 |
1.3 |
8 |
0.9 |
36 |
0.7 |
12000 |
20 |
0.8 |
102 |
1.0 |
6 |
0.7 |
32 |
0.7 |
2-AA |
235 |
10.1* |
540 |
5.2* |
43 |
5.0* |
634 |
13.1* |
2-AA: 2-aminoanthracene,3 µg/plate
* = mutagenic effect
** =bacteriotoxic effect
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results:
negative without metabolic activation
negative with metabolic activation - Executive summary:
Herbold BA (1987)
NaF (as a surrogate for fluorosulphuric acid) was investigated in a Salmonella / microsome test for point-mutagenic effects in doses up to 12500 µg per plate on four Salmonella typhimurium LT2 mutants with and without metabolic activation. Test was performed similar to the OECD guideline 471 with restrictions (Only four strains, no strains with AT base pair as primary reversion site. Different positive control substances used in comparison with OECD guideline. Culture media used: not reported).
For the test the histidine-auxotrophic strains TA 1535, TA 100, TA 1537 and TA 98 were used.
Doses up to and including 6000 µg per plate did not cause any bacteriotoxic effects. The total bacteria counts remained unchanged. No inhibition of growth was observed.
At higher doses, the substance had only a bacteriotoxic effect in TA 1535 and TA 100, so that this range could nevertheless be used for evaluation purposes. Substance precipitation occurred from the dose 500 µg per plate.
Evidence of mutagenic activity for NaF was not found with and without metabolic activation. Neither a dose-related doubling of the mutant count nor a biologically relevant increase in the same, was observed in comparison with the negative controls.
The positive controls sodium azide (Na-azide) , nitrofurantoin (NF), 4-nitro-1,2-phenylene-diamine (4-NPDA), and 2-aminoanthracene (2 -AA) had a marked mutagenic effect, as can be seen from the biologically relevant increase in mutant colonies, compared to the corresponding negative controls.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.